VONENTIAL

Serial Number 97353394
733

Registration Progress

Application Filed
Apr 8, 2022
Under Examination
Apr 25, 2023
Approved for Publication
Feb 28, 2023
Published for Opposition
Feb 28, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Oct 25, 2027 631 days

Trademark Image

VONENTIAL

Basic Information

Serial Number
97353394
Filing Date
April 8, 2022
Published for Opposition
February 28, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Mar 31, 2025
Application
Pending
Classes
005

Rights Holder

Agouron Pharmaceuticals, LLC

16
Address
10646 Science Center Drive
San Diego, CA 92121

Ownership History

Agouron Pharmaceuticals, LLC

Original Applicant
16
San Diego, CA

Agouron Pharmaceuticals, LLC

Owner at Publication
16
San Diego, CA

Legal Representation

Attorney
Heather A. McDonald

USPTO Deadlines

Next Deadline
631 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
October 25, 2027
Extension Available
Until April 25, 2026

Application History

29 events
Date Code Type Description Documents
Jan 28, 2026 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jan 28, 2026 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 28, 2026 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 28, 2026 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 24, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 1, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 31, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Mar 31, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 31, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 10, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 10, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 10, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 10, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 10, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 9, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 9, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 9, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 10, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 6, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 6, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 6, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 25, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 28, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 28, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 8, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 26, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 26, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 12, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 12, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification

International Classes
005